[Prognostic factors in malignant glioma in elderly patients].
Nishihara
Masamitsu
M
Department of Neurosurgery, Hyogo Medical Center for Adults.
Taomoto
Katsushi
K
Kohmura
Eiji
E
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001931:Brain Mapping; D001932:Brain Neoplasms / Q000175:diagnosis / Q000235:genetics / Q000401:mortality / Q000628:therapy; D002879:Chromosomes, Human, Pair 10 / Q000235:genetics; D003131:Combined Modality Therapy; D019583:Dose Fractionation, Radiation; D016158:Genes, p53 / Q000235:genetics; D005910:Glioma / Q000175:diagnosis / Q000235:genetics / Q000401:mortality / Q000628:therapy; D006801:Humans; D019656:Loss of Heterozygosity; D008279:Magnetic Resonance Imaging; D016093:Mason-Pfizer monkey virus; D009154:Mutation; D038361:Neuronavigation; D019635:Neurosurgical Procedures / Q000379:methods; D011379:Prognosis; D020266:Radiotherapy, Conformal